Literature DB >> 1467777

Colorectal carcinoma in Indian patients with idiopathic ulcerative colitis.

R Kochhar1, M K Goenka, S P Kaushik, N M Gupta, B Nagi, S K Mehta.   

Abstract

In contrast to reports from Western countries, the incidence of colorectal carcinoma among patients with idiopathic ulcerative colitis is considered to be low in the Indian subcontinent. In order to assess the risk of carcinoma in Indian patients, a retrospective analysis of 436 cases of idiopathic ulcerative colitis seen by us over a period of 12 years was carried out. Eight cases of colitis carcinoma (1.8%) were encountered during the study period. Pancolitis was present in six of them while colitis was of limited extent in two cases. The mean duration of colitis prior to development of carcinoma was 12.1 (range 7-25) years. While four of these patients were on our follow-up list and were diagnosed to have carcinoma at the time of a medical or surgical complication, four others first presented to us with a surgical complication of colitis carcinoma. We conclude that colitis carcinoma is not a rare entity among Indian patients with idiopathic ulcerative colitis. We feel that until proved otherwise, patients with idiopathic ulcerative colitis from the Indian subcontinent should not be denied the benefits of a cancer surveillance programme.

Entities:  

Mesh:

Year:  1992        PMID: 1467777     DOI: 10.1097/00008469-199206000-00003

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  14 in total

1.  Colorectal cancers in ulcerative colitis from a low-prevalence area for colon cancer.

Authors:  Devendra Desai; Sudeep Shah; Abhijit Deshmukh; Philip Abraham; Anand Joshi; Tarun Gupta; Ramesh Deshpande; Varun Khandagale; Siji George
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 2.  Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis.

Authors:  Sawan Bopanna; Ashwin N Ananthakrishnan; Saurabh Kedia; Vijay Yajnik; Vineet Ahuja
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-02-21

3.  A low-cost method for chromoendoscopy for surveillance in ulcerative colitis.

Authors:  Sawan Bopanna; Saurabh Kedia; Vineet Ahuja
Journal:  Indian J Gastroenterol       Date:  2016-11-23

4.  Study of p53 and bcl-2 Oncoproteins in Ulcerative Colitis with Dysplasia.

Authors:  P Kinra; Spv Turlapati; A Mehta; Ramji Rai
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

Review 6.  Colorectal cancer surveillance in inflammatory bowel disease: A critical analysis.

Authors:  Devendra Desai; Nutan Desai
Journal:  World J Gastrointest Endosc       Date:  2014-11-16

7.  Long-term follow-up reveals high incidence of colorectal cancer in Indian patients with inflammatory bowel disease.

Authors:  Sawan Bopanna; Saurabh Kedia; Prasenjit Das; S Dattagupta; V Sreenivas; V Pratap Mouli; Rajan Dhingra; Rajesh Pradhan; N Suraj Kumar; Dawesh P Yadav; Govind Makharia; Vineet Ahuja
Journal:  United European Gastroenterol J       Date:  2016-11-17       Impact factor: 4.623

8.  Inflammatory bowel disease in India--changing paradigms.

Authors:  Gautam Ray
Journal:  Int J Colorectal Dis       Date:  2010-11-10       Impact factor: 2.571

9.  Copy number variations are progressively associated with the pathogenesis of colorectal cancer in ulcerative colitis.

Authors:  Bhadravathi Marigowda Shivakumar; Harish Rotti; Thanvanthri Gururajan Vasudevan; Aswath Balakrishnan; Sanjiban Chakrabarty; Ganesh Bhat; Lakshmi Rao; Cannanore Ganesh Pai; Kapaettu Satyamoorthy
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

Review 10.  Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East.

Authors:  Saurabh Kedia; Vineet Ahuja
Journal:  Inflamm Intest Dis       Date:  2017-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.